JPWO2023120535A5 - - Google Patents
Info
- Publication number
- JPWO2023120535A5 JPWO2023120535A5 JP2023569467A JP2023569467A JPWO2023120535A5 JP WO2023120535 A5 JPWO2023120535 A5 JP WO2023120535A5 JP 2023569467 A JP2023569467 A JP 2023569467A JP 2023569467 A JP2023569467 A JP 2023569467A JP WO2023120535 A5 JPWO2023120535 A5 JP WO2023120535A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine adjuvant
- molecular weight
- high molecular
- vaccine
- weight polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021206279 | 2021-12-20 | ||
| PCT/JP2022/046937 WO2023120535A1 (ja) | 2021-12-20 | 2022-12-20 | ポリアクリル酸系ポリマーを含有するワクチンアジュバント剤およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023120535A1 JPWO2023120535A1 (https=) | 2023-06-29 |
| JPWO2023120535A5 true JPWO2023120535A5 (https=) | 2025-12-24 |
Family
ID=86902542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023569467A Pending JPWO2023120535A1 (https=) | 2021-12-20 | 2022-12-20 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250057945A1 (https=) |
| EP (1) | EP4454661A4 (https=) |
| JP (1) | JPWO2023120535A1 (https=) |
| KR (1) | KR20240122803A (https=) |
| CN (1) | CN118450903A (https=) |
| AU (1) | AU2022423668A1 (https=) |
| CA (1) | CA3241333A1 (https=) |
| IL (1) | IL313632A (https=) |
| MX (1) | MX2024007693A (https=) |
| WO (1) | WO2023120535A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2025005260A1 (https=) * | 2023-06-28 | 2025-01-02 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2009004900A1 (ja) | 2007-06-29 | 2010-08-26 | 学校法人 城西大学 | ユビキノン含有免疫アジュバント |
| GB0805356D0 (en) * | 2008-03-25 | 2008-04-30 | Isis Innovation | Vaccine adjuvant composition |
| EP2679242B1 (en) * | 2011-02-25 | 2020-09-09 | Hisamitsu Pharmaceutical Co., Inc. | Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing same |
| HK1209646A1 (en) * | 2012-12-28 | 2016-04-08 | 日本国立感染症研究所 | Nasal influenza vaccine composition |
| JP2018020962A (ja) * | 2014-12-08 | 2018-02-08 | エヌエーアイ株式会社 | 新規アジュバント |
| BR112018076015A8 (pt) * | 2016-06-17 | 2022-06-28 | Sanofi Pasteur | Formulações imunogênicas compreendendo adjuvantes de polímero do ácido poliacrílico linear ou ramificado . |
-
2022
- 2022-12-20 AU AU2022423668A patent/AU2022423668A1/en active Pending
- 2022-12-20 US US18/721,547 patent/US20250057945A1/en active Pending
- 2022-12-20 CN CN202280083912.2A patent/CN118450903A/zh active Pending
- 2022-12-20 KR KR1020247022394A patent/KR20240122803A/ko active Pending
- 2022-12-20 CA CA3241333A patent/CA3241333A1/en active Pending
- 2022-12-20 EP EP22911237.0A patent/EP4454661A4/en active Pending
- 2022-12-20 WO PCT/JP2022/046937 patent/WO2023120535A1/ja not_active Ceased
- 2022-12-20 IL IL313632A patent/IL313632A/en unknown
- 2022-12-20 JP JP2023569467A patent/JPWO2023120535A1/ja active Pending
- 2022-12-20 MX MX2024007693A patent/MX2024007693A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Angeli et al. | SARS-CoV-2 vaccines: Lights and shadows | |
| Chen et al. | Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement | |
| JP2026026092A5 (https=) | ||
| McKee et al. | Old and new adjuvants | |
| Zaman et al. | Strategies for intranasal delivery of vaccines | |
| Lee et al. | Nasal delivery of chitosan/alginate nanoparticle encapsulated bee (Apis mellifera) venom promotes antibody production and viral clearance during porcine reproductive and respiratory syndrome virus infection by modulating T cell related responses | |
| US12318440B2 (en) | VLP stabilized vaccine compositions | |
| JP2003508439A5 (https=) | ||
| AU2013353580B2 (en) | Oral gel for sensitivity and tooth pain | |
| JP2003526673A5 (https=) | ||
| JP2010539172A5 (https=) | ||
| JPWO2023120535A5 (https=) | ||
| CN104837481B (zh) | 用于减轻牙齿疼痛的口用凝胶 | |
| Liu et al. | Self-assembling nanovaccine enhances protective efficacy against CSFV in pigs | |
| JP2022515103A (ja) | 免疫アジュバント組成物及びその調製方法並びに応用 | |
| JP2003509470A5 (https=) | ||
| WO2023108083A3 (en) | Nanoparticle immunogenic compositions and vaccination methods | |
| Zhang et al. | Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases | |
| Adair | Nanoparticle vaccines against respiratory viruses | |
| Debnath et al. | Potential application of bionanoparticles to treat severe acute respiratory syndrome coronavirus-2 infection | |
| JP7618632B2 (ja) | 経鼻ｂ型肝炎ワクチン組成物およびその製造方法 | |
| Xing et al. | Efficient mucosal immunization by mucoadhesive and ph-sensitive polymeric vaccine delivery system | |
| CN111789943B (zh) | 一种水包油佐剂组合物及其制备方法和应用 | |
| JP2023099200A (ja) | アジュバントおよび該アジュバントを含むワクチン | |
| JP2024520730A5 (https=) |